Doing Business At the intersection of science, law, and policy

Your global business partners for addressing legal, scientific, and regulatory challenges.

Competitive Advantage

Bergeson & Campbell, P.C. (B&C®), a Washington D.C. law firm focusing on conventional, biobased, and nanoscale industrial, agricultural, and specialty chemical product approval and regulation, product defense, and associated business issues. 

We help companies that make and use chemicals commercialize their products, maintain compliance, and gain competitive advantage as they market their products throughout the world. Our Mission is to get them to market faster and more efficiently than the competition.

More About Us
Lab and planting seeds

Knowledge & Insights

  March 25, 2024
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  May 21, 2024
Registration Now Open for “TSCA Reform — Eight Years Later” Conference

Registration is now open for “TSCA Reform — Eight Years Later,” the June 26, 2024, day-long conference sponsored by Bergeson & Campbell,...

  May 17, 2024
EPA Holds Webinar on “Reducing PFAS in Products: Progress and Challenges”

On May 8, 2024, the U.S. Environmental Protection Agency’s (EPA) Office of Chemical Safety and Pollution Prevention (OCSPP) held a webinar on...

  May 16, 2024
EPA, FDA, and USDA Issue Joint Regulatory Plan for Biotechnology

On May 8, 2024, the U.S. Environmental Protection Agency (EPA), U.S. Food and Drug Administration (FDA), and the U.S. Department of Agriculture (USDA)...

  May 15, 2024
Monthly Federal Developments Memorandum
Recent Federal Developments for May 2024


  May 14, 2024
EPA Amends Procedural Framework Rule for Conducting TSCA Risk Evaluations

The U.S. Environmental Protection Agency (EPA) released a final rule on April 23, 2024, that amends the procedural framework rule for conducting risk...

  May 10, 2024
EPA Accepting Comment on Proposed Consent Decrees to Settle Lawsuits Challenging Time to Complete TSCA Risk Evaluations

On April 26, 2024, the U.S. Environmental Protection Agency (EPA) requested comment on proposed consent decrees that would address lawsuits filed by...

Seminars & Webinars

  April 11, 2024
Seminars & Webinars
Sponsor’s Role in Regulatory Testing — Complying with GLP Standards, June 12, 2024, 11:00 a.m. – 12:00 p.m. (EDT), via webinar

Register now to join Bergeson & Campbell, P.C. (B&C®) and The Acta Group (Acta®) for “Sponsor’s Role in Regulatory Testing —...

  May 16, 2024
Seminars & Webinars
There Is More to TSCA Reporting Than CDR: TSCA Sections 8(a), (c), (d), and (e), featuring Dave Turk and Stephanie Griffin from EPA OCSPP, June 18, 2024, 11:00 a.m. – 12:00 p.m. (EDT), via webinar

The U.S. Environmental Protection Agency (EPA) has been using its Toxic Substances Control Act (TSCA) Section 8 authorities in new and different ways....

  March 20, 2024
Seminars & Webinars
TSCA Reform – 8 Years Later, June 26, 2024, George Washington University Milken Institute School of Public Health, Washington, D.C., and via livestream

Save the date to join Bergeson & Campbell, P.C. (B&C®), the Environmental Law Institute (ELI), and the George Washington University...

We partner with our clients to help them get products quickly and efficiently to market–in any country or locale–and keep them there.

Our Firms
Map of Bergeson & Campbell locations

our people

Government affairs experts, including eight high-level EPA alumni. Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, seven Ph.D.'s. Trusted, respected, and highly rated attorneys who have worked on some of the toughest regulatory and legal issues of our time.

B&C, Acta, and BCCM provide a full range of global support for the commercialisation of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.

Hexagons image collage

A true business partner with clients, B&C delivers vital expertise in business strategy development, compliance planning, product defense, policy advocacy, and related activities.